Handel Novartis Adr Repsg 1 - USD - NVS CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.12 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.024068% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | 0.001846% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | USD | ||||||||
Margen | 20% | ||||||||
Aktiebørs | United States of America | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Novartis AG ESG Risk Ratings
‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 83.56 |
Åben* | 82.95 |
1-Års Ændring* | -3.64% |
Dagens Spænd* | 81.88 - 83.32 |
52-Ugers Spænd | 74.09-94.26 |
Gennemsnitlig Volumen (10 dage) | 2.31M |
Gennemsnitlig Volumen (3 måneder) | 41.57M |
Market Cap | 188.52B |
P/E-forhold | 26.47 |
Udestående aktier | 2.12B |
Omsætning | 51.74B |
EPS | 3.16 |
Dividend (Udbytte %) | 4.18155 |
Beta | 0.52 |
Næste indtjeningsopgørelse | Apr 25, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 22, 2023 | 81.88 | -0.98 | -1.18% | 82.86 | 83.35 | 81.62 |
Mar 21, 2023 | 83.56 | -0.02 | -0.02% | 83.58 | 83.76 | 82.99 |
Mar 20, 2023 | 83.34 | 0.52 | 0.63% | 82.82 | 83.40 | 82.43 |
Mar 17, 2023 | 82.14 | -0.58 | -0.70% | 82.72 | 83.05 | 81.87 |
Mar 16, 2023 | 82.72 | 0.49 | 0.60% | 82.23 | 82.85 | 81.75 |
Mar 15, 2023 | 82.04 | 0.82 | 1.01% | 81.22 | 82.36 | 81.19 |
Mar 14, 2023 | 82.07 | 0.27 | 0.33% | 81.80 | 82.12 | 81.16 |
Mar 13, 2023 | 81.58 | 0.22 | 0.27% | 81.36 | 82.40 | 81.35 |
Mar 10, 2023 | 80.63 | 0.00 | 0.00% | 80.63 | 81.13 | 80.16 |
Mar 9, 2023 | 79.99 | -0.77 | -0.95% | 80.76 | 80.85 | 79.70 |
Mar 8, 2023 | 83.23 | -0.43 | -0.51% | 83.66 | 83.85 | 82.99 |
Mar 7, 2023 | 83.94 | -0.93 | -1.10% | 84.87 | 84.95 | 83.57 |
Mar 6, 2023 | 84.87 | 0.02 | 0.02% | 84.85 | 85.59 | 84.50 |
Mar 3, 2023 | 84.63 | 0.18 | 0.21% | 84.45 | 84.84 | 84.27 |
Mar 2, 2023 | 85.04 | 1.07 | 1.27% | 83.97 | 85.21 | 83.58 |
Mar 1, 2023 | 83.76 | -0.46 | -0.55% | 84.22 | 84.45 | 83.50 |
Feb 28, 2023 | 84.05 | -1.02 | -1.20% | 85.07 | 85.15 | 83.66 |
Feb 27, 2023 | 85.44 | -0.67 | -0.78% | 86.11 | 86.15 | 85.32 |
Feb 24, 2023 | 85.57 | -0.72 | -0.83% | 86.29 | 86.30 | 85.27 |
Feb 23, 2023 | 86.50 | 0.01 | 0.01% | 86.49 | 86.73 | 85.74 |
Novartis Adr Repsg 1 - USD Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Total omsætning | 52877 | 49898 | 48624 | 46017 | 43361 |
Omsætning | 52877 | 49898 | 48624 | 46017 | 43361 |
Kost af omsætning, Total | 15435 | 14400 | 13930 | 13555 | 13416 |
Bruttofortjeneste | 37442 | 35498 | 34694 | 32462 | 29945 |
Totale Driftsudgifter | 41188 | 39746 | 39538 | 31824 | 34658 |
Salgs/Generelle/Admin. Udgifter, Total | 14815 | 14093 | 14319 | 13690 | 12468 |
Forskning & Udvikling | 9041 | 8484 | 8386 | 8154 | 7808 |
Depreciation / Amortization | 109 | 64 | 50 | 179 | 187 |
Usædvanlig Udgift (Indkomst) | 1173 | 2503 | 2284 | -4309 | 395 |
Other Operating Expenses, Total | 653 | 538 | 607 | 549 | 384 |
Driftsindtægter | 11689 | 10152 | 9086 | 14193 | 8703 |
Renteindkomst (Udgift), Netto Ikke-Drift | 14628 | -146 | -36 | -5 | 418 |
Andre, Netto | -180 | -128 | -110 | -93 | -19 |
Netto Indkomst Før Skat | 26137 | 9878 | 8940 | 14095 | 9102 |
Netto Indkomst Efter Skat | 24018 | 8071 | 7147 | 12800 | 7499 |
Minoritetsrente | 3 | 1 | -5 | -3 | 0 |
Netto Indkomst Før Ekstra Ting | 24021 | 8072 | 7142 | 12797 | 7499 |
Netto Indkomst | 24021 | 8072 | 11732 | 12611 | 7703 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 24021 | 8072 | 7142 | 12797 | 7499 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 24021 | 8072 | 11732 | 12611 | 7703 |
Fortyndelsesændring | |||||
Fortyndet Netto Indkomst | 24021 | 8072 | 11732 | 12611 | 7703 |
Fortyndet Vægtet Gennemsnit Aktier | 2260 | 2296 | 2319 | 2344 | 2371 |
Fortyndet EPS Uden Ekstraordinære Ting | 10.6288 | 3.51568 | 3.07978 | 5.45947 | 3.1628 |
Dividends per Share - Common Stock Primary Issue | 3.19907 | 3.08737 | 2.83413 | 2.93645 | 2.71776 |
Fortyndet Normaliseret EPS | 11.1183 | 4.40641 | 3.86715 | 3.79006 | 3.30006 |
Totale Ekstraordinære Ting | 4590 | -186 | 204 | ||
Renteudgift (Indkomst) - Netto Drift | -38 | -336 | -38 | 6 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Total omsætning | 12814 | 13522 | 13367 | 13294 | 12694 |
Omsætning | 12814 | 13522 | 13367 | 13294 | 12694 |
Kost af omsætning, Total | 3755 | 4000 | 3848 | 3754 | 3833 |
Bruttofortjeneste | 9059 | 9522 | 9519 | 9540 | 8861 |
Totale Driftsudgifter | 9962 | 10960 | 10134 | 9815 | 10279 |
Salgs/Generelle/Admin. Udgifter, Total | 3498 | 3984 | 3601 | 3710 | 3520 |
Forskning & Udvikling | 2256 | 2369 | 2261 | 2284 | 2127 |
Depreciation / Amortization | 35 | 30 | 25 | 27 | 27 |
Renteudgift (Indkomst) - Netto Drift | 102 | 12 | -9 | 60 | -101 |
Usædvanlig Udgift (Indkomst) | 193 | 307 | 312 | -136 | 690 |
Other Operating Expenses, Total | 123 | 258 | 96 | 116 | 183 |
Driftsindtægter | 2852 | 2562 | 3233 | 3479 | 2415 |
Renteindkomst (Udgift), Netto Ikke-Drift | -203 | 14415 | 21 | 38 | 54 |
Andre, Netto | 20 | -26 | -24 | -11 | -19 |
Netto Indkomst Før Skat | 2669 | 16951 | 3230 | 3506 | 2450 |
Netto Indkomst Efter Skat | 2219 | 16306 | 2758 | 2895 | 2059 |
Minoritetsrente | 3 | 2 | 0 | 1 | 0 |
Netto Indkomst Før Ekstra Ting | 2222 | 16308 | 2758 | 2896 | 2059 |
Netto Indkomst | 2222 | 16308 | 2758 | 2896 | 2059 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 2222 | 16308 | 2758 | 2896 | 2059 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 2222 | 16308 | 2758 | 2896 | 2059 |
Fortyndet Netto Indkomst | 2222 | 16308 | 2758 | 2896 | 2059 |
Fortyndet Vægtet Gennemsnit Aktier | 2237 | 2257 | 2254 | 2243 | 2265 |
Fortyndet EPS Uden Ekstraordinære Ting | 0.99329 | 7.22552 | 1.2236 | 1.29113 | 0.90905 |
Dividends per Share - Common Stock Primary Issue | 0 | 3.19907 | 0 | 0 | 0 |
Fortyndet Normaliseret EPS | 1.06502 | 7.35637 | 1.3418 | 1.24106 | 1.16507 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 45718 | 29673 | 29504 | 35563 | 28208 |
Likvider og Kortsigtede Investeringer | 28113 | 11293 | 11234 | 15718 | 9347 |
Cash | 3396 | 3750 | 3247 | 3121 | 2970 |
Likvider & Lignende | 9011 | 5908 | 7865 | 10150 | 5890 |
Kortsigtede Investeringer | 15706 | 1635 | 122 | 2447 | 487 |
Totale Tilgodehavender, Netto | 9621 | 10036 | 10337 | 11036 | 11101 |
Accounts Receivable - Trade, Net | 8005 | 8217 | 8301 | 8739 | 8601 |
Total Inventory | 6666 | 7131 | 5982 | 6956 | 6867 |
Prepaid Expenses | 1102 | 943 | 898 | 812 | 756 |
Other Current Assets, Total | 216 | 270 | 1053 | 1041 | 137 |
Total Assets | 131795 | 127778 | 118370 | 145563 | 133079 |
Property/Plant/Equipment, Total - Net | 13106 | 13939 | 13746 | 15696 | 16464 |
Property/Plant/Equipment, Total - Gross | 28708 | 29894 | 28676 | 34028 | 34010 |
Accumulated Depreciation, Total | -15602 | -15955 | -14930 | -18332 | -17546 |
Goodwill, Net | 29595 | 29999 | 26524 | 35294 | 31750 |
Intangibles, Net | 34182 | 36809 | 28787 | 38719 | 29997 |
Long Term Investments | 2268 | 11611 | 10538 | 9789 | 16645 |
Note Receivable - Long Term | 973 | 922 | 624 | 908 | 968 |
Other Long Term Assets, Total | 5953 | 4825 | 8647 | 9594 | 9047 |
Total Current Liabilities | 30208 | 33059 | 28264 | 29607 | 23403 |
Accounts Payable | 5553 | 5403 | 5424 | 5556 | 5169 |
Accrued Expenses | 5100 | 5336 | 5058 | 5105 | 4811 |
Notes Payable/Short Term Debt | 3606 | 7319 | 4844 | 6430 | 4842 |
Current Port. of LT Debt/Capital Leases | 2896 | 2558 | 2248 | 3190 | 359 |
Other Current Liabilities, Total | 13053 | 12443 | 10690 | 9326 | 8222 |
Total Liabilities | 64140 | 71180 | 62896 | 66949 | 58911 |
Total Long Term Debt | 24523 | 27978 | 22056 | 22470 | 23224 |
Long Term Debt | 22902 | 26259 | 20353 | 22470 | 23224 |
Deferred Income Tax | 3070 | 3141 | 5867 | 7475 | 5168 |
Minority Interest | 167 | 68 | 77 | 78 | 59 |
Other Liabilities, Total | 6172 | 6934 | 6632 | 7319 | 7057 |
Total Equity | 67655 | 56598 | 55474 | 78614 | 74168 |
Common Stock | 901 | 913 | 936 | 944 | 969 |
Retained Earnings (Accumulated Deficit) | 70989 | 57157 | 59274 | 82191 | 77639 |
Treasury Stock - Common | -48 | -53 | -80 | -69 | -100 |
Unrealized Gain (Loss) | 206 | 386 | |||
Other Equity, Total | -4187 | -1419 | -4656 | -4658 | -4726 |
Total Liabilities & Shareholders’ Equity | 131795 | 127778 | 118370 | 145563 | 133079 |
Total Common Shares Outstanding | 2234.94 | 2256.82 | 2265.01 | 2311.17 | 2317.46 |
Capital Lease Obligations | 1621 | 1719 | 1703 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 37236 | 45718 | 26253 | 23808 | 22198 |
Likvider og Kortsigtede Investeringer | 18814 | 28329 | 8162 | 5356 | 4077 |
Likvider & Lignende | 13852 | 12407 | 7211 | 5117 | 3801 |
Kortsigtede Investeringer | 4962 | 15922 | 951 | 239 | 276 |
Totale Tilgodehavender, Netto | 8678 | 8283 | 8632 | 8654 | 8481 |
Accounts Receivable - Trade, Net | 8409 | 8005 | 8377 | 8400 | 8265 |
Total Inventory | 6997 | 6666 | 6885 | 7111 | 6997 |
Other Current Assets, Total | 2747 | 2440 | 2574 | 2687 | 2643 |
Total Assets | 125218 | 131795 | 121209 | 124015 | 121752 |
Property/Plant/Equipment, Total - Net | 12861 | 13106 | 13157 | 13344 | 13204 |
Goodwill, Net | 29636 | 29595 | 29572 | 29766 | 29590 |
Intangibles, Net | 34853 | 34182 | 33951 | 34818 | 35377 |
Long Term Investments | 2906 | 3241 | 12347 | 12014 | 11628 |
Other Long Term Assets, Total | 7726 | 5953 | 5929 | 10265 | 9755 |
Total Current Liabilities | 29807 | 30208 | 29880 | 29633 | 30160 |
Accounts Payable | 5083 | 5553 | 4665 | 4811 | 5040 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 6902 | 6502 | 9528 | 9278 | 10400 |
Other Current Liabilities, Total | 17822 | 18153 | 15687 | 15544 | 14720 |
Total Liabilities | 63678 | 64140 | 64438 | 69973 | 71229 |
Total Long Term Debt | 24373 | 24523 | 24715 | 26491 | 27399 |
Long Term Debt | 22796 | 22902 | 23101 | 24828 | 25747 |
Capital Lease Obligations | 1577 | 1621 | 1614 | 1663 | 1652 |
Deferred Income Tax | 3384 | 3070 | 3349 | 7472 | 7393 |
Minority Interest | 164 | 167 | 166 | 86 | 66 |
Other Liabilities, Total | 5950 | 6172 | 6328 | 6291 | 6211 |
Total Equity | 61540 | 67655 | 56771 | 54042 | 50523 |
Common Stock | 901 | 901 | 901 | 913 | 913 |
Retained Earnings (Accumulated Deficit) | 60699 | 66802 | 55917 | 53194 | 49670 |
Treasury Stock - Common | -60 | -48 | -47 | -65 | -60 |
Total Liabilities & Shareholders’ Equity | 125218 | 131795 | 121209 | 124015 | 121752 |
Total Common Shares Outstanding | 2212.58 | 2234.94 | 2237.09 | 2236.74 | 2245.09 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 24018 | 8071 | 7147 | 12800 | 7499 |
Likvider Fra Driftsaktiviteter | 15071 | 13650 | 13625 | 14272 | 12621 |
Likvider Fra Driftsaktiviteter | 1807 | 2088 | 1852 | 1783 | 1460 |
Amortization | 4306 | 4376 | 3974 | 3428 | 3276 |
Ikke-Likvide Ting | -11714 | 3842 | 3369 | -2315 | 1983 |
Cash Taxes Paid | 2342 | 1833 | 1876 | 1506 | 1487 |
Likvid Rente Betalt | 664 | 703 | 793 | 816 | 697 |
Ændringer i Driftskapital | -3346 | -4727 | -2717 | -1424 | -1597 |
Likvider fra Investeringsaktiviteter | 4208 | -13182 | -2226 | -5591 | -3119 |
Kapitaludgifter | -2971 | -2585 | -2257 | -2648 | -2294 |
Andre Investerings-Cash-Flow-Ting, Total | 7179 | -10597 | 31 | -2943 | -825 |
Likvider fra Financieringsaktiviteter | -16264 | -2208 | -13627 | -4244 | -7733 |
Financiering af Cash-Flow-Ting | 94 | -199 | 3307 | -119 | -101 |
Total Cash Dividends Paid | -7368 | -6987 | -6645 | -6966 | -6495 |
Udstedelse (Pensionering) af Aktier, Netto | -3004 | -2094 | -5332 | -1336 | -5238 |
Udstedelse (Pensionering) af Gæld, Netto | -5986 | 7072 | -4957 | 4177 | 4101 |
Udenlandsk Børs Effekter | -266 | 286 | 69 | -26 | 84 |
Netto Ændring i Likviditet | 2749 | -1454 | -2159 | 4411 | 1853 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 2219 | 24018 | 7712 | 4954 | 2059 |
Cash From Operating Activities | 1649 | 15071 | 11187 | 6262 | 2130 |
Cash From Operating Activities | 392 | 1807 | 1287 | 893 | 514 |
Amortization | 1013 | 4306 | 3307 | 2248 | 1183 |
Non-Cash Items | 918 | -11714 | 1732 | 803 | 386 |
Cash Taxes Paid | 633 | 2342 | 1459 | 1144 | 735 |
Cash Interest Paid | 110 | 664 | 458 | 301 | 112 |
Changes in Working Capital | -2893 | -3346 | -2851 | -2636 | -2012 |
Cash From Investing Activities | 9365 | 4208 | -355 | 877 | 780 |
Capital Expenditures | -859 | -2971 | -1994 | -1455 | -858 |
Other Investing Cash Flow Items, Total | 10224 | 7179 | 1639 | 2332 | 1638 |
Cash From Financing Activities | -9528 | -16264 | -13013 | -11479 | -8540 |
Financing Cash Flow Items | 22 | 94 | 87 | 77 | -35 |
Total Cash Dividends Paid | -7506 | -7368 | -7368 | -7368 | -7368 |
Issuance (Retirement) of Stock, Net | -2448 | -3004 | -2856 | -2572 | -1892 |
Issuance (Retirement) of Debt, Net | 404 | -5986 | -2876 | -1616 | 755 |
Foreign Exchange Effects | -41 | -266 | -266 | -201 | -227 |
Net Change in Cash | 1445 | 2749 | -2447 | -4541 | -5857 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
Dodge & Cox | Investment Advisor/Hedge Fund | 0.979 | 20751372 | -297285 | 2022-12-31 | LOW |
PRIMECAP Management Company | Investment Advisor | 0.8112 | 17194880 | -258270 | 2022-12-31 | LOW |
Loomis, Sayles & Company, L.P. | Investment Advisor/Hedge Fund | 0.5164 | 10945998 | -3983754 | 2022-12-31 | LOW |
Franklin Mutual Advisers, LLC | Investment Advisor/Hedge Fund | 0.3121 | 6615062 | -495110 | 2022-12-31 | LOW |
Dimensional Fund Advisors, L.P. | Investment Advisor/Hedge Fund | 0.2828 | 5993485 | -509706 | 2022-12-31 | LOW |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 0.229 | 4854407 | -233195 | 2022-12-31 | LOW |
Charles Schwab Investment Management, Inc. | Investment Advisor | 0.2155 | 4568714 | 41253 | 2022-12-31 | LOW |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 0.1947 | 4127082 | 2498355 | 2022-12-31 | MED |
Managed Account Advisors LLC | Investment Advisor | 0.1908 | 4043458 | -1491223 | 2022-12-31 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 0.1856 | 3933293 | 594023 | 2022-12-31 | LOW |
Morgan Stanley Smith Barney LLC | Investment Advisor | 0.1663 | 3525896 | 170517 | 2022-12-31 | LOW |
Renaissance Technologies LLC | Hedge Fund | 0.1614 | 3420970 | 239100 | 2022-12-31 | HIGH |
Schafer Cullen Capital Management, Inc. | Investment Advisor/Hedge Fund | 0.1315 | 2787713 | -679560 | 2022-12-31 | LOW |
Parametric Portfolio Associates LLC | Investment Advisor | 0.1249 | 2647981 | -49658 | 2022-12-31 | LOW |
Principal Global Investors (Equity) | Investment Advisor | 0.1163 | 2466037 | 7806 | 2022-12-31 | LOW |
Northern Trust Global Investments | Investment Advisor | 0.1123 | 2379524 | -95663 | 2022-12-31 | LOW |
Two Sigma Investments, LP | Hedge Fund | 0.1075 | 2279635 | -1267963 | 2022-12-31 | HIGH |
UBS Financial Services, Inc. | Investment Advisor | 0.0983 | 2082692 | -258460 | 2022-12-31 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.0891 | 1888357 | -38920 | 2022-12-31 | LOW |
Wells Fargo Advisors | Research Firm | 0.086 | 1822796 | -161869 | 2022-12-31 | LOW |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Novartis ADR Company profile
Om Novartis Adr Repsg 1 - USD
Novartis AG er en schweizisk lægemiddelvirksomhed. Virksomheden udvikler, fremstiller og markedsfører receptpligtig medicin, aktive farmaceutiske ingredienser (API'er), biosimilære lægemidler og øjenlægeprodukter. Virksomheden anvender videnskabelige og digitale teknologier til behandlinger inden for sygdomsområderne immunologi, dermatologi, kræft, oftalmologi, neurovidenskab, respiratorik, kardiovaskulær medicin, nyrebehandling og metabolisme. Selskabets forretningsaktiviteter er opdelt i to segmenter: Innovative Medicines, som omfatter innovative patentbeskyttede receptpligtige lægemidler mod blodtryk, kræft og andre lidelser, og Sandoz, som omfatter generiske lægemidler og biosimilars.
Industry: | Pharmaceuticals (NEC) |
Lichtstrasse 35
BASEL
BASEL-STADT 4056
CH
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com